Search Results - "MORRISSEY, Colm M"

Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy by Bhatia, Vipul, Kamat, Nikhil V., Pariva, Tiffany E., Wu, Li-Ting, Tsao, Annabelle, Sasaki, Koichi, Sun, Huiyun, Javier, Gerardo, Nutt, Sam, Coleman, Ilsa, Hitchcock, Lauren, Zhang, Ailin, Rudoy, Dmytro, Gulati, Roman, Patel, Radhika A., Roudier, Martine P., True, Lawrence D., Srivastava, Shivani, Morrissey, Colm M., Haffner, Michael C., Nelson, Peter S., Priceman, Saul J., Ishihara, Jun, Lee, John K.

“…Six transmembrane epithelial antigen of the prostate 1 (STEAP1) is a cell surface antigen for therapeutic targeting in prostate cancer. Here, we report broad…”
Get full text

ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis by Rotinen, Mirja, You, Sungyong, Yang, Julie, Coetzee, Simon G., Reis-Sobreiro, Mariana, Huang, Wen-Chin, Huang, Fangjin, Pan, Xinlei, Yáñez, Alberto, Hazelett, Dennis J., Chu, Chia-Yi, Steadman, Kenneth, Morrissey, Colm M., Nelson, Peter S., Corey, Eva, Chung, Leland W. K., Freedland, Stephen J., Di Vizio, Dolores, Garraway, Isla P., Murali, Ramachandran, Knudsen, Beatrice S., Freeman, Michael R.

“…Treatment of prostate cancer (PC) by androgen suppression promotes the emergence of aggressive variants that are androgen receptor (AR) independent. Here we…”
Get full text

Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer by HOLCOMB, Ilona N, YOUNG, Janet M, NELSON, Peter S, VESSELLA, Robert L, TRASK, Barbara J, COLEMAN, Ilsa M, SALARI, Keyan, GROVE, Douglas I, HSU, Li, TRUE, Lawrence D, ROUDIER, Martine P, MORRISSEY, Colm M, HIGANO, Celestia S

“…Androgen deprivation is the mainstay of therapy for progressive prostate cancer. Despite initial and dramatic tumor inhibition, most men eventually fail…”
Get full text

Abstract 5249: LuCaP prostate cancer xenografts: Models that allow clinically relevant investigation of prostate cancer in a preclinical setting by Nguyen, Holly M., Morrissey, Colm M., Nelson, Peter S., Zhang, Xiaotun, Plymate, Stephen R., Higano, Celestia S., Lange, Paul H., True, Lawrence D., Roudier, Martine PM, Vessella, Robert L., Corey, Eva

“…Abstract PCa is an extremely heterogeneous disease and generating relevant data invariably requires the use of multiple models. A paucity of pre-clinical…”
Get full text

Abstract 3302: Profiling prostate cancer metastases by Morrissey, Colm M., Dowell, Alex, Roudier, Martine, Ketchandji, Melanie, Zhang, Xiaotun, Chen, Shu, Colman, Ilsa, Corey, Eva, Montgomery, Robert, Lange, Paul, Knudsen, Beatrice, Nelson, Peter, True, Lawrence, Higano, Celestia, Vessella, Robert

“…Abstract Introduction: Prostate cancer (PCa) metastasizes to a number of sites, however, it has a propensity to metastasize to bone. There is considerable…”
Get full text